The weight-loss drug rimonabant increases the risk of anxiety and depression, reported four newspapers (16 November 2007). The reports were based on the findings of an analysis of four clinical trials that found rimonabant led to greater weight-loss than placebo, but was associated with a greater number of adverse events.